Still from Australian National University (ANU) - https://youtu.be/5x82jaMmhmA
Malaysia: Urine screening before concerts? Drug policy advocates explain why that may do more harm than good
KUALA LUMPUR, Jan 20 — Selangor’s Local Government and Tourism Committee chairman Datuk Ng Suee Lim recently proposed urine screening to detect drug use among ravers or concert-goers.
The proposal followed the deaths of four people who attended the New Year's Eve Pinkfish Festival in Sunway here.
Post-mortem reports indicated they died from complications caused by the drugs they consumed, likely to be ecstasy in pill form. Three other attendees were also hospitalised because they were suspected of taking the same pills.
There were mixed reactions to the proposal. Drug policy advocates suggested urine screening may not be effective at all, and could actually do more harm. The National Anti-Drug Agency, meanwhile, said the idea was impractical.
Why is urine screening may not be a good idea?
Palani Narayanan, Director of Drug Policy Program Malaysia, said urine screening is inherently defective as a solution to drug use problems
“Firstly, urine screening can only tell you if someone used a drug in the short past, say three weeks before, so someone who hasn’t taken a drug in six months will likely test negative,” he said.
“Now when they consume a drug at the music festival after having not taken anything in the last six months, just a small dose of drugs can be fatal because their tolerance level is lower than someone who takes drugs regularly,” he added.
“This person has a higher chance of fatal overdose and urine tests are useless to identify this.”
Then there is the cost factor. Urine screening is expensive. In the US, urine drug screening costs billions of dollars annually. Between 2011 and 2014, the cost of urine tests were reported to be around US$8.5 billion.
There is no available data on how much enforcement agencies spent on urine screening, but drug policy advocates believe it could reach hundreds of millions in the past ten years.
Palani said it makes little sense to pour money into a defective system that could be better spent on harm reduction measures like the health care workers who can advise people on the safety of the drugs they take.